Giansun Precision Technology Group
001400
Heilongjiang Tianyouwei Electronics
603202
Joy Kie Corporation
300994
4
Kingchem
301509
5
Hunan Er-kang Pharmaceutical
300267
CN Stock MarketDetailed Quotes
688256 Cambricon
- 691.96
- +6.75+0.99%
Market Closed Apr 24 15:00 CST
288.86BMarket Cap2224.95P/E (TTM)
694.88High679.00Low43.58KlotVolume685.21Open685.21Pre Close2.99BTurnover1.04%Turnover RatioLossP/E (Static)417.46MShares818.8752wk High49.56P/B288.86BFloat Cap156.5052wk Low822.25Limit Up417.46MShs Float818.87Historical High548.17Limit Down2.32%Amplitude46.59Historical Low--Dividend TTM687.12Avg Price18.33KlotAsk--Div YieldTTM100Lot Size20.30KlotBid
Cambricon Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 543.09%757.5M | 109.30%1.8B | -56.74%266.89M | -14.02%199.04M | 45.80%117.79M | 77.87%857.9M | 189.04%616.95M | 119.53%231.49M | 23.35%80.79M | -2.87%482.32M |
| Refunds of taxes and levies | ---- | -98.59%237.5K | -98.60%237.5K | -98.60%237.5K | -99.12%148.07K | -62.68%16.88M | -62.49%16.97M | -60.96%16.97M | --16.89M | 60.08%45.24M |
| Cash received relating to other operating activities | -57.01%8.11M | 197.65%506.87M | 642.26%477.45M | 754.58%425.19M | -11.31%18.86M | 58.32%170.29M | -19.67%64.32M | -20.38%49.75M | -32.11%21.27M | -61.20%107.56M |
| Cash inflows from operating activities | 459.65%765.61M | 120.34%2.3B | 6.63%744.57M | 109.40%624.46M | 15.01%136.8M | 64.55%1.05B | 106.12%698.25M | 41.07%298.21M | 22.85%118.95M | -20.81%635.12M |
| Goods services cash paid | 1,163.18%1.87B | 616.43%3.09B | 581.85%1.89B | 573.12%761.41M | 142.19%147.69M | -40.38%430.77M | -51.47%277.03M | -66.81%113.12M | -69.56%60.98M | 32.47%722.5M |
| Staff behalf paid | 41.29%265.23M | -24.07%706.78M | -26.17%565.99M | -24.15%426M | -27.03%187.73M | -9.34%930.86M | -3.28%766.64M | -6.04%561.62M | 6.55%257.25M | 25.09%1.03B |
| All taxes paid | 0.01%4.51M | -92.21%7.28M | -78.21%5.44M | -78.14%5.15M | -77.31%4.51M | 264.63%93.47M | 106.97%24.96M | 101.11%23.57M | 74.30%19.89M | 290.63%25.63M |
| Cash paid relating to other operating activities | -4.56%29.56M | -35.06%120.48M | -38.90%93.93M | -35.86%63.12M | -37.28%30.98M | -2.42%185.51M | 27.21%153.72M | 3.92%98.41M | 32.11%49.39M | -37.13%190.1M |
| Cash outflows from operating activities | 483.69%2.16B | 138.98%3.92B | 108.96%2.55B | 57.61%1.26B | -4.29%370.91M | -16.51%1.64B | -18.31%1.22B | -23.75%796.71M | -21.01%387.52M | 17.30%1.96B |
| Net cash flows from operating activities | -497.73%-1.4B | -171.68%-1.62B | -245.29%-1.81B | -26.62%-631.22M | 12.83%-234.11M | 55.22%-595.54M | 54.73%-524.11M | 40.19%-498.51M | 31.79%-268.57M | -52.31%-1.33B |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | -66.96%760M | -5.90%7.5B | 6.02%5.11B | -5.91%2.39B | 90.08%2.3B | -39.68%7.97B | -54.76%4.82B | -67.03%2.54B | -73.08%1.21B | -24.11%13.2B |
| Cash received from returns on investments | -85.12%2.36M | -51.36%38.83M | -32.79%32.25M | 60.36%18.16M | 174.01%15.87M | 14.00%79.84M | -11.96%47.98M | -70.27%11.32M | -73.51%5.79M | -22.79%70.04M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | ---- | 50.74%268.07K | 41,865.00%251.79K | --91.79K | --5.62K | --177.84K | --600 | ---- | ---- | ---- |
| Net cash received from disposal of subsidiaries and other business units | ---- | --1.5M | --1.5M | --1.5M | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash received relating to other investing activities | ---- | -88.33%70M | -88.33%70M | ---- | ---- | 500.00%600M | --600M | ---- | ---- | -92.11%100M |
| Cash inflows from investing activities | -67.08%762.36M | -12.02%7.61B | -4.65%5.21B | -5.55%2.41B | 90.48%2.32B | -35.36%8.65B | -48.94%5.46B | -67.05%2.55B | -73.08%1.22B | -28.70%13.37B |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | 343.44%168.27M | 264.65%366.05M | 245.86%211.18M | 155.01%116.64M | 62.27%37.95M | -64.67%100.38M | -74.58%61.06M | -75.48%45.74M | -74.86%23.38M | -43.73%284.14M |
| Cash paid to acquire investments | -68.15%520M | -5.76%7.59B | -13.41%6.21B | 2.09%4.21B | 11.71%1.63B | -30.68%8.05B | -28.20%7.17B | -47.71%4.12B | -68.06%1.46B | -36.10%11.61B |
| Cash paid relating to other investing activities | ---- | -7.83%64.52M | ---- | ---- | ---- | -90.00%70M | -88.00%72M | --70M | ---- | --700M |
| Cash outflows from investing activities | -58.80%688.27M | -2.47%8.02B | -12.09%6.42B | 2.06%4.32B | 12.51%1.67B | -34.74%8.22B | -32.54%7.3B | -47.48%4.24B | -68.19%1.48B | -32.56%12.6B |
| Net cash flows from investing activities | -88.52%74.1M | -196.94%-411.65M | 34.22%-1.21B | -13.56%-1.91B | 339.79%645.24M | -45.36%424.66M | -1,371.39%-1.84B | -418.15%-1.69B | -77.38%-269.08M | 880.40%777.14M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | -96.89%56.05M | -96.87%56.05M | ---- | ---- | 715.50%1.8B | 1,092.31%1.79B | 1,092.31%1.79B | ---- | 29.78%221.15M |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | ---- | ---- | ---- | ---- | -85.98%24.5M | -90.54%9.8M | -90.87%9.8M | ---- | 2.52%174.7M |
| Cash from borrowing | ---- | --100M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash received relating to other financing activities | ---- | --2.92M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash inflows from financing activities | ---- | -91.19%158.97M | -96.87%56.05M | ---- | ---- | 715.50%1.8B | 1,092.31%1.79B | 1,092.31%1.79B | ---- | 29.78%221.15M |
| Dividend interest payment | --775K | --82.8K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash payments relating to other financing activities | -52.91%8.03M | -24.29%111M | -73.75%33.22M | -73.38%24.75M | -76.06%17.05M | 19.63%146.61M | 36.88%126.59M | 40.28%92.97M | 228.61%71.22M | 71.63%122.55M |
| Cash outflows from financing activities | -48.36%8.8M | -24.23%111.08M | -73.75%33.22M | -73.38%24.75M | -76.06%17.05M | 19.63%146.61M | 36.88%126.59M | 40.28%92.97M | 228.61%71.22M | 71.63%122.55M |
| Net cash flows from financing activities | 48.36%-8.8M | -97.11%47.89M | -98.63%22.83M | -101.46%-24.75M | 76.06%-17.05M | 1,580.41%1.66B | 2,788.42%1.66B | 1,924.85%1.7B | -351.16%-71.22M | -0.40%98.6M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -308.95%-2.8K | -104.02%-15.15K | -112.92%-49.51K | -109.43%-28.99K | 101.26%1.34K | -35.75%376.94K | -51.06%383.13K | -28.51%307.64K | -172.42%-106.86K | 369.12%586.68K |
| Net increase in cash and cash equivalents | -438.52%-1.33B | -233.32%-1.98B | -328.26%-3B | -426.47%-2.57B | 164.71%394.08M | 427.74%1.49B | 42.86%-699.57M | 54.57%-488.27M | -17.76%-608.98M | 34.75%-453.54M |
| Add:Begin period cash and cash equivalents | -50.12%1.97B | 60.24%3.95B | 60.24%3.95B | 60.24%3.95B | 60.24%3.95B | -15.53%2.47B | -15.53%2.47B | -15.53%2.47B | -15.53%2.47B | -19.22%2.92B |
| End period cash equivalent | -85.33%637.9M | -50.12%1.97B | -45.82%957.73M | -30.11%1.38B | 133.96%4.35B | 60.24%3.95B | 4.19%1.77B | 7.20%1.98B | -22.69%1.86B | -15.53%2.47B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | -- | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.